181 related articles for article (PubMed ID: 12724314)
1. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.
Wang YH; Tsay YG; Tan BC; Lo WY; Lee SC
J Biol Chem; 2003 Jul; 278(28):25568-76. PubMed ID: 12724314
[TBL] [Abstract][Full Text] [Related]
2. DNA damage activates p53 through a phosphorylation-acetylation cascade.
Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
4. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
[TBL] [Abstract][Full Text] [Related]
5. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
Gu W; Roeder RG
Cell; 1997 Aug; 90(4):595-606. PubMed ID: 9288740
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of the BETA2 transcription factor by p300-associated factor is important in insulin gene expression.
Qiu Y; Guo M; Huang S; Stein R
J Biol Chem; 2004 Mar; 279(11):9796-802. PubMed ID: 14701848
[TBL] [Abstract][Full Text] [Related]
7. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription.
Ceseña TI; Cardinaux JR; Kwok R; Schwartz J
J Biol Chem; 2007 Jan; 282(2):956-67. PubMed ID: 17110376
[TBL] [Abstract][Full Text] [Related]
10. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
Knights CD; Liu Y; Appella E; Kulesz-Martin M
J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction.
Lévy L; Wei Y; Labalette C; Wu Y; Renard CA; Buendia MA; Neuveut C
Mol Cell Biol; 2004 Apr; 24(8):3404-14. PubMed ID: 15060161
[TBL] [Abstract][Full Text] [Related]
12. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.
Kobet E; Zeng X; Zhu Y; Keller D; Lu H
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12547-52. PubMed ID: 11070080
[TBL] [Abstract][Full Text] [Related]
13. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
[TBL] [Abstract][Full Text] [Related]
15. Max is acetylated by p300 at several nuclear localization residues.
Faiola F; Wu YT; Pan S; Zhang K; Farina A; Martinez E
Biochem J; 2007 May; 403(3):397-407. PubMed ID: 17217336
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.
Espinosa JM; Emerson BM
Mol Cell; 2001 Jul; 8(1):57-69. PubMed ID: 11511360
[TBL] [Abstract][Full Text] [Related]
17. Probing lysine acetylation in proteins: strategies, limitations, and pitfalls of in vitro acetyltransferase assays.
Dormeyer W; Ott M; Schnölzer M
Mol Cell Proteomics; 2005 Sep; 4(9):1226-39. PubMed ID: 15933374
[TBL] [Abstract][Full Text] [Related]
18. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
Shiseki M; Nagashima M; Pedeux RM; Kitahama-Shiseki M; Miura K; Okamura S; Onogi H; Higashimoto Y; Appella E; Yokota J; Harris CC
Cancer Res; 2003 May; 63(10):2373-8. PubMed ID: 12750254
[TBL] [Abstract][Full Text] [Related]
19. Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding.
Caillaud A; Prakash A; Smith E; Masumi A; Hovanessian AG; Levy DE; Marié I
J Biol Chem; 2002 Dec; 277(51):49417-21. PubMed ID: 12374802
[TBL] [Abstract][Full Text] [Related]
20. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
